Mike Cintolo
Cabot Top Ten Trader
Geoffrey Seiler
Bullmarket.com
Sy Harding
Street Smart Report
Nicholas Vardy
Bull Market Alert

Citigroup: Banking turnaround?


Bookmark and Share
by Geoffrey Seiler, editor BullMarket.com

Geoffrey SeilerFinancial stocks were among the best-performing sectors of the market in the first quarter as firms put the struggles of the mortgage meltdown, financial crisis, and ensuing recession behind them.

Citigroup (C) reported profits ahead of Wall Street's consensus forecast, though revenue was a lit lower than expected. The bank did a good job of holding the line on its operating costs and its tier 1 capital ratio improved to 12.4% from 11.8% in the fourth quarter.

Citigroup earned $2.9 billion for the first three months of this year, equal to 95 cents per share. Excluding items the bank would have earned $1.11 per share, which was 10 cents per share better than the Wall Street consensus estimate.

The bank's international reach was a benefit during the quarter as it was able to take advantage of the struggles of European banks to increase international transaction services revenue by 7% to $2.7 billion. Emerging markets were also a strong point as revenue grew by 6% in Latin America to $2.4 billion and by 5% in Asia to $2.0 billion.


Citi Holdings is the entity Citicorp created to be the repository for the billions in toxic assets it accumulated leading up to the financial crisis. While it continues to wind down that legacy portfolio, it still represented 11% of the bank's total assets as of March 31st.

The banking sector is gradually improving as it works its way past headwinds like the Durbin debit rules and sluggish loan demand. Citi's results were a mixed bag, but it is in significantly better shape than it was several years ago.

Give CEO Vikram Pandit some credit. It was often joked that he only got the job because no one else wanted it, but despite being dealt a tough hand, he has made the most of the opportunity given to him.

The bank has staged an impressive comeback, aided by the rather significant help of the American taxpayer, but since the government cashed in its chips in 2010, Citigroup has continued to improve.

One of the most noteworthy changes is that management now has its operating costs under control and is looking to lower them further. Considering this once was a bank that was synonymous with bloat and excess, it has been a remarkable turnaround.

Trading well under tangible book value of about $51, the stock is cheap, but it's also cheap for a reason given the trouble it had gotten itself into prior to Pandit taking over as CEO and the toxic assets it still holds.

However, things are looking up and this international banking behemoth remains an interesting higher risk/reward play on a banking turnaround.

Learn more about this financial newsletter at Geoffrey Seiler's BullMarket.com.

Related articles:

Advertisement
Banner
News Flash

Express Scripts: Obamacare buy
by J. Royden Ward, editor Cabot Benjamin Graham Value Investor

I am attracted to healthcare stocks because the confusion surrounding “ObamaCare” has held healthcare stock prices back. I think Express Scripts (ESRX) is very likely to shine in 2013.


Read more...

 

Hodges: High conviction funds
by Walter Frank, editor MoneyLetter

Over the last two months, Hodges Fund (HDPMX) has made a strong run to the top echelons of our domestic stock fund rankings. And one of its siblings, Hodges Small Cap (HDPSX) has been within the top decline of the small blend category from 2009 through last year, and is in the top 20% this year.


Read more...


   

United Natural: A play on Whole Foods
by Mark Skousen, editor Hedge Fund Trader Alert

We’ve recommended Whole Foods Market (WFM) from time to time, and the stock has moved up sharply in the past three years, but I’d like to suggest an alternative -- one of Whole Foods’ primary suppliers, United Natural Foods (UNFI).


Read more...

 

Timing expert eyes India
by Sy Harding, editor Street Smart Report

The money flow and momentum reversals in India's Bombay Index have now been enough to trigger buy signals on intermediate-term indicators. With this new buy signal, we have added a position in the iShares India 50 ETF (INDY) to our portfolio.


Read more...

 

Value investor goes with Guess
by Charles Mizrahi, editor Hidden Values Alert

Guess?, Inc. (GES) is a holding in our special situation portfolio; its strong product quality has created brand name recognition and a loyal consumer following.


Read more...

 

MGAM: Bingo, lotteries, casinos
by Jim Oberweis, Jr., editor The Oberweis Report

Multimedia Games Holding Company (MGAM) makes innovative gaming systems for Native American and commercial casino operators in North America, lottery operators, and charity and commercial bingo operators.


Read more...

 

Fidelity expert: Bowers' bond bets
by Jack Bowers, editor Fidelity Monitor & Insight

If you’ve been worried that the bond market might take a big hit, you can relax. Indeed, while bond funds may lag stock funds over the next 5-10 years, they still have a decent shot at keeping up with inflation, and they remain an excellent way to cut risk in a blended portfolio.


Read more...

 

Tesla: 'Out of the ball park'
by Timothy Lutts. editor Cabot Stock of the Month

Tesla (TSLA), our previously featured Stock of the Month and our top stock pick for 2013, knocked the ball out of the park in its latest quarter. The company exceeded analysts' expectations on all counts: cars sold, revenues, earnings, gross margins and more.


Read more...

 

5 ways to speculate on Cuba
by Jim Powell, editor Global Changes & Opportunities Report

With the death of Hugo Chavez in March, and Venezuela’s economic decline, the heavily subsidized oil lifeline is likely to be cut or sharply reduced. I think the resulting energy squeeze will force Cuba to allow greater foreign trade and investment.


Read more...

 

Big gains in nanotechnology?
by Doug Fabian, editor Making Money Alert

The nanotechnology niche focuses on very small, even microscopic, technology. Nanotech has produced technological developments in medicine (lasers), electronics (ink jet systems) and biomaterials (chemical and bio-detectors).


Read more...

 



Banner



Close
Select Offer: Schwab Options Market Commentary